Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Cellegy submits NDS for Rectogesic approval in Canada

March 27, 2002

Licensing opportunity from NIH: use of CpG oligodeoxynucleotides to promote angiogenesis

March 26, 2002

Novel antibiotic for acne enters phase I testing

March 26, 2002

Daclizumab fails to meet endpoint as maintenance treatment in psoriasis

March 22, 2002

Investigators at Shiseido identify new MMP inhibitors

March 21, 2002

Centocor patents series of anti-IL-12 antibodies

March 21, 2002

First European country approves Elidel for atopic dermatitis

March 19, 2002

Optimal treatment regimen for Vasogen's immune modulation therapy identified

March 18, 2002

Protopic cleared for launch in Europe

March 15, 2002

New nonsteroidal therapy for atopic eczema effective in over two-thirds of adults

March 14, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...